| Adult-onset immunodeficiency in Thailand and Taiwan SK Browne, PD Burbelo, P Chetchotisakd, Y Suputtamongkol, ... New England Journal of Medicine 367 (8), 725-734, 2012 | 507 | 2012 |
| Iridium complexes of CCC-pincer N-heterocyclic carbene ligands: synthesis and catalytic C− H functionalization AR Chianese, A Mo, NL Lampland, RL Swartz, PT Bremer Organometallics 29 (13), 3019-3026, 2010 | 152 | 2010 |
| Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice HH Chang, A Moro, K Takakura, HY Su, A Mo, M Nakanishi, RT Waldron, ... PloS one 12 (9), e0184455, 2017 | 128 | 2017 |
| Iridium complexes of bulky CCC-pincer N-heterocyclic carbene ligands: steric control of coordination number and catalytic alkene isomerization AR Chianese, SE Shaner, JA Tendler, DM Pudalov, DY Shopov, D Kim, ... Organometallics 31 (21), 7359-7367, 2012 | 102 | 2012 |
| Flexible, bowl-shaped N-heterocyclic carbene ligands: Substrate specificity in iridium-catalyzed ketone hydrosilylation AR Chianese, A Mo, D Datta Organometallics 28 (2), 465-472, 2009 | 67 | 2009 |
| Determination of human anticytokine autoantibody profiles using a particle-based approach L Ding, A Mo, K Jutivorakool, M Pancholi, SM Holland, SK Browne Journal of clinical immunology 32, 238-245, 2012 | 56 | 2012 |
| CDKN2A copy number loss is an independent prognostic factor in HPV-negative head and neck squamous cell carcinoma WS Chen, RS Bindra, A Mo, T Hayman, Z Husain, JN Contessa, ... Frontiers in oncology 8, 95, 2018 | 40 | 2018 |
| Distinct Transcriptional Changes and Epithelial–Stromal Interactions Are Altered in Early-Stage Colon Cancer Development A Mo, S Jackson, K Varma, A Carpino, C Giardina, TJ Devers, ... Molecular Cancer Research 14 (9), 795-804, 2016 | 27 | 2016 |
| Colorectal polyp prevention by daily aspirin use is abrogated among active smokers DA Drew, G Goh, A Mo, JJ Grady, F Forouhar, G Egan, H Swede, ... Cancer Causes & Control 27, 93-103, 2016 | 26 | 2016 |
| Tracheotomy in a high-volume center during the COVID-19 pandemic: evaluating the surgeon’s risk AG Thal, BA Schiff, Y Ahmed, A Cao, A Mo, V Mehta, RV Smith, ... Otolaryngology–Head and Neck Surgery 164 (3), 522-527, 2021 | 22 | 2021 |
| Characterization of mucosal dysbiosis of early colonic neoplasia B Hong, T Ideta, BS Lemos, Y Igarashi, Y Tan, M DiSiena, A Mo, JW Birk, ... NPJ Precision Oncology 3 (1), 29, 2019 | 21 | 2019 |
| Proximal aberrant crypt foci associate with synchronous neoplasia and are primed for neoplastic progression DA Drew, A Mo, JJ Grady, RG Stevens, JB Levine, BM Brenner, ... Molecular Cancer Research 16 (3), 486-495, 2018 | 15 | 2018 |
| Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital System A Mo, J Chung, J Eichler, S Yukelis, S Feldman, J Fox, M Garg, S Kalnicki, ... Breast, 301-307, 2021 | 12 | 2021 |
| Associations of dietary fat with risk of early neoplasia in the proximal colon in a population-based case–control study A Mo, R Wu, JP Grady, MP Hanley, M Toro, H Swede, TJ Devers, ... Cancer Causes & Control 29, 667-674, 2018 | 9 | 2018 |
| Predictors of financial toxicity in patients receiving concurrent radiation therapy and chemotherapy JM Jiang, J Eichler, W Bodner, J Fox, M Garg, R Kabarriti, A Mo, ... Advances in Radiation Oncology 8 (3), 101141, 2023 | 5 | 2023 |
| COVID-19 incidentally detected on PET/CT during work-up for locally advanced head and neck cancer A Mo, NP Brodin, WA Tomé, MK Garg, R Kabarriti in vivo 34 (3 suppl), 1681-1684, 2020 | 5 | 2020 |
| Targeted transcriptional profiling of microdissected biopsy specimens representing early colonic neoplasia A Mo, S Jackson, TJ Devers, DW Rosenberg Journal of cellular biochemistry 117 (12), 2677-2681, 2016 | 4 | 2016 |
| CDKN2A copy number loss in HPV-and HPV+ head and neck cancer to indicate poor prognosis: An integrated genomic and clinical TCGA analysis. WS Chen, R Bindra, A Mo, T Hayman, Z Husain, JN Contessa, ... Journal of Clinical Oncology 35 (15_suppl), 6060-6060, 2017 | 3 | 2017 |
| A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum DL Gillen, FL Meyskens, TR Morgan, JA Zell, R Carroll, R Benya, ... Cancer Prevention Research 8 (3), 222-230, 2015 | 3 | 2015 |
| A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum G D.L., M F.L., Morgan T.R, Z J., C R., B R., C W.P., T C., B A., H Z., A M., ... Cancer Prev Res (Phila), 2015 | 3* | 2015 |
Daniel W RosenbergUCONN Health CenterVerified email at uchc.edu
